Insulin glargine, recombinant Subcutaneous and Lenvima (18 MG Daily Dose)
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Lenvima (18 MG Daily Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvima
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Lenvima (20 MG Daily Dose)
- Insulin glargine, recombinant Subcutaneous-Lenvima (24 MG Daily Dose)
- Insulin glargine, recombinant Subcutaneous-Lenvima (8 MG Daily Dose)
- Insulin glargine, recombinant Subcutaneous-Lenvima 10 MG Daily Dose
- Insulin glargine, recombinant Subcutaneous-Lenvima 12 MG Daily Dose
- Insulin glargine, recombinant Subcutaneous-Lenvima 4 MG Daily Dose
- Lenvima (18 MG Daily Dose)-Insulin glulisine
- Lenvima (18 MG Daily Dose)-Insulin Glulisine (Cartridges and Pens)
- Lenvima (18 MG Daily Dose)-Insulin Glulisine (Vials)
- Lenvima (18 MG Daily Dose)-Insulin glulisine Subcutaneous
- Lenvima (18 MG Daily Dose)-Insulin human inhaled Inhalation
- Lenvima (18 MG Daily Dose)-Insulin human regular Injection